All News

/All News

Mologic Develops New Lateral Flow Testing Platform, Partners With West African Dx Center

By |2019-05-16T17:11:39+01:00May 16th, 2019|

NEW YORK (360Dx) – British diagnostics company Mologic has completed development of a next-generation lateral flow testing platform that it claims improves sensitivity significantly. The Bedford, UK-based firm is also working with a new center in Dakar, Senegal, that will deploy new tests based on the platform to support [...]

Mologic achieves breakthrough in ultra-sensitive point-of-care diagnostics and develops new platform technology

By |2019-05-07T08:59:21+01:00May 7th, 2019|

Visually-read device delivers up to 1,000-fold improvement in sensitivity to support surveillance and elimination efforts of global epidemics Since 2016, the Bill & Melinda Gates Foundation has committed $9.7 million to establish and accelerate the CARD technology programme Bedfordshire, UK, 7 May 2019: Mologic Ltd, a leading developer of [...]

Mologic expands US and UK operations

By |2019-04-01T10:06:14+01:00April 1st, 2019|

Strengthens team as part of continued international expansion Bolsters US presence with the opening of subsidiary in Boston, MA Doubles device manufacturing capacity in UK Bedfordshire, UK, 1 April 2019: Mologic Ltd, a leading developer of lateral flow and rapid diagnostic technologies, services and products, today announced it has [...]

FIND LAUNCHES NEW SCHISTOSOMIASIS PROGRAMME

By |2019-03-14T15:22:04+01:00March 14th, 2019|

Today the Foundation for Innovative New Diagnostics (FIND) is leading a consortium, of which Mologic is part, announced the launch of a new schistosomiasis programme within its neglected tropical disease portfolio. FIND is leading a consortium which along with the WHO is developing novel rapid diagnostic tests for schistosomiasis infection that affects over 206 million people across 78 tropical and sub-tropical countries

Developing In-Home Respiratory, Professional-Use Sepsis Diagnostics for US Launch

By |2018-11-29T09:34:52+01:00October 8th, 2018|

In a recent interview with 360Dx, Mark Davis discussed how Mologic continues to develop it’s strong pipeline of rapid POC diagnostics and begins to look into the North American market for expansion and strategic partners... NEW YORK (360Dx) – Mologic is expanding into the US market and targeting the near-term commercialization of rapid [...]

MOLOGIC COMMENCES CLINICAL TRIAL OF URINE-BASED DIAGNOSTIC FOR CYSTIC FIBROSIS

By |2018-11-29T09:34:52+01:00August 2nd, 2018|

Bedfordshire, UK, 02 August 2018: Mologic Ltd, a developer of powerful, personalised diagnostics to improve the lives of patients, today announced that it has commenced a clinical trial to evaluate the Company’s urine-based diagnostic, HeadsUp, in monitoring pulmonary exacerbation in cystic fibrosis (CF) patients. The study aims to identify five [...]

FIND ANNOUNCES NEW WAVE OF ACTIVITIES TO ADDRESS HCV ELIMINATION

By |2018-11-29T09:34:53+01:00August 1st, 2018|

The Foundation for Innovative New Diagnostics (FIND) announced last Friday that it has awarded grants to a number of companies to address the urgent diagnostic needs for hepatitis C virus (HCV). These grants will be used to conduct feasibility studies of various technologies that could transform HCV testing at [...]

US FDA approved Krintafel (tafenoquine) for the radical cure of P.vivax in malaria

By |2018-11-29T09:34:53+01:00July 23rd, 2018|

GSK and Medicines for Malaria Venture (MMV) today announced that the United States Food and Drug Administration (FDA) has approved, under Priority Review, single-dose Krintafel(tafenoquine) for the radical cure (prevention of relapse) of Plasmodium vivax (P. vivax) malaria in patients aged 16 years and older who are receiving appropriate antimalarial therapy for acute P. vivax infection. Read [...]

Mologic and Newcastle University launch BReD

By |2018-11-29T09:34:53+01:00June 12th, 2018|

Mologic and Newcastle University launch BReD diagnostic for blackgrass resistance at Cereals Bedfordshire and Newcastle, UK, 13 June 2018: Mologic Ltd, a developer of personalised diagnostics, and Newcastle University, today announced they have developed an on-farm blackgrass resistance diagnostic (BReD). The one-step, rapid lateral flow product for detecting glutathione transferase (AmGSTF1) [...]

Load More Posts